Pluslife (Guangzhou Pluslife Technology Co., Ltd.) is a biotechnology company based in Guangzhou, China, founded in 2017. The company specializes in portable molecular point-of-care testing (mPOCT) diagnostics for humans and pets, utilizing its proprietary RHAM (RNase Hybridization Assisted Amplification) technology. Pluslife aims to enhance global healthcare accessibility by providing reliable and user-friendly testing solutions for infectious diseases and pathogens in companion animals. The company offers a range of products, including the Palm-Sized Mini Dock Molecular POC System, which delivers qPCR-level accuracy at primary care costs. Key offerings include molecular POCT devices and test cards for various infectious diseases, such as COVID-19 and tuberculosis, as well as solutions tailored for pet hospitals and diagnostic facilities. Pluslife has developed over 30 workflow solutions and maintains a commitment to affordability and simplicity in its products. Pluslife collaborates with notable organizations like the Gates Foundation and Global Fund, supporting healthcare initiatives in low- and middle-income countries. The company has achieved significant milestones, including mass production of its products and recognition as a leading biotech firm in the Guangdong-Hong Kong-Macao Greater Bay Area.
Enter your details and select criteria for the jobs you want to receive.
This role at an unspecified company will build and validate a capital-efficient U.S. veterinary market-entry path before major USDA or manufacturing investment.
